Skip to content

Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty

Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty Within an Enhanced Recovery Programme - a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02478372
Enrollment
242
Registered
2015-06-23
Start date
2010-04-30
Completion date
2012-11-30
Last updated
2015-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

local infiltration analgesia, Epidural, Enhanced Recovery, Total Knee Arthroplasty

Brief summary

The purpose of this study was to determine if the method of peri-operative analgesia used following total Knee Replacement surgery affected the progress towards rehabilitation goals and to determine whether the analgesia had any impact on long term outcomes.

Detailed description

Enhanced Recovery Programmes (ERP) as defined by Henrik Kehlet have been established within orthopaedics within the United Kingdom in a number of centres (Malviya et al., 2011, McDonald et al., 2012, Scott et al., 2013) demonstrating improvements in patient outcomes. However as the ERP involved in all of these papers are a redesign of a number of key elements of the clinical pathway it remains unclear as to the level of significance each component may have on the patient's reported outcomes. The use of Local Infiltration Analgesia (LIA) as the primary post-operative analgesic technique has grown in popularity in Scotland over the past 5 years (Scott et al., 2013). A number of large cohort series have concurrently reported significant improvements in early ambulation and shortened lengths of stay (Malviya et al., 2011, McDonald et al., 2012) yet it remains unclear as to whether this is due to the introduction and use of the LIA technique or the overall development of the ERP programmes. The aim of this parallel group randomised controlled trial was to test two different methods of regional analgesia (LIA and Epidural) and their impact on attainment of predetermined rehabilitation criteria for direct discharge home and to consider the impact of each technique on long term functional status up to one year post surgery. Epidural analgesia when utilised as post-operative analgesia is predominantly used in the format of a continuous infusion of a set volume of analgesia (+/- adjuncts such as fentanyl) resulting in both a motor and sensory blockade, which as would be expected increases with the volume infused. Ambulatory patient epidurals have been used for a number of years within maternity services which provide adequate pain relief whilst enabling the patient to be mobile (Stewart & Fernando, 2011). Therefore to provide a fairer comparison with the LIA technique the standard epidural analgesia technique within the Golden Jubilee National Hospital was adapted to a Patient Controlled Epidural Analgesia (PCEA) system with no background infusion. The planned long term follow up period ( One year) was developed to enable greater evidence of the impact of each method on functional capacity, Patient Reported Outcome Scores (PROMS) and to monitor the incidence of adverse incidents over a longer period of time than previously published literature.

Interventions

DRUGPatient Controlled Epidural (PCEA)

Following the operation, 4ml of 0.25% levobupivacaine was administered and the catheter was connected to a PCEA. Self-medication with a bolus 2ml of 0.125% bupivacaine via the PCEA system with a lockout time of 15 minutes until the following morning (post-operative day one) when it was stopped.

Subcutaneous infiltration during surgery using 200ml of 0.2% plain ropivacaine.

Sponsors

Glasgow Caledonian University
CollaboratorOTHER
Golden Jubilee National Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients (age\> 18years old) undergoing primary unilateral total knee arthroplasty (TKA) with a clinical diagnosis of osteoarthritis

Exclusion criteria

* Patients planned for uni-compartmental/bilateral or revision knee surgery patients * Patients with a diagnosis of rheumatoid arthritis (RA) * Patients with coagulation or anatomical defects e.g. preventing the use of spinal anaesthesia * Known allergies to any medications within the trial * Patients who were unable to give written informed consent * Patients requiring pre-operative catheterisation for urinary outflow dysfunction * Known neurological incident that would limit or make impossible early ambulation following surgery

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Patients Discharged From Rehabilitation by Day Four96 hours% of patients meeting predetermined discharge criteria at 96 Hours post-surgery. The discharge criteria were: self dependent (dress, personal care); in and out of bedd independently; up and down stairs; walk with crutches/stick; 80 degrees knee flexion; able to straight leg raise operated limb.

Secondary

MeasureTime frameDescription
Verbal Rating Score (VRS) Pain Scores24hours, 48 hours and 72 hours post-surgerySummary 24 hour Verbal rated numerical pain scores were gathered each day. Scale range 0-10 where 0 is no pain and 10 is worst imaginable pain
Post-operative Urinary Catheterisation Rates72 hours post-surgery% of patients requiring catheterisation for urinary retention post-surgery
Post-operative Nausea and Vomiting Scores24hours, 48 hours and 72 hours post-surgerypercentage of patients reporting either symptoms of nausea or vomiting over the first 72 hours following surgery. Scale 0-2 wherein 0=no nausea and vomiting, 1=nausea and 2= nausea and vomiting
Average Post-operative Length of StayAverage number of days spent in hospital follwoing surgery, an expected average of 5 daysParticipants will be followed for the duration of hospital stay, an expected average of 5 days
Maximal Flexion Angle of the Operative Knee at Discharge From RehabilitationOn day of discharge from rehabilitation in-patient care (average 96 hours post surgery)
Patient Reported Outcome Measure - Oxford Knee Scoreone week prior to surgery, 6 weeks post-surgery , one year post-surgeryUnits measured on old Oxford Score (12-60) from a 12 point questionnaire. Where in 60 is poor and lower scores are better patient reported outcome scores
Total Number of Reported Participants With Complications and/or Adverse Events30 days and one year post-surgeryThe composite number of adverse events reported per group at 30 days and then one year post surgery
Day of Ambulationtheatre day, day 1 post-surgery, day two post-surgeryProportion of patients per day to ambulate for the first time with the physiotherapist \> 3 Metres

Participant flow

Participants by arm

ArmCount
Patient Controlled Epidural (PCEA)
A lumbar epidural was sited following establishment of the spinal blockade. Following the completion of the operation, patients received 4ml of 0.25% levobupivacaine prior to leaving the operating room. Thereafter they were connected to a PCEA pump (McKinley 545) with no background infusion. Patients could self-medicate with a bolus 2ml of 0.125% bupivacaine via the PCEA system with a lockout time of 15 minutes until the following morning (post-operative day one). Nurse-administered rescue top-ups of 4ml of 0.25% levobupivacaine were available for insufficient analgesia. The epidural catheter was removed on the morning of post-operative day two (POD2).
121
Local Infiltration Analgesia (LIA)
Subcutaneous infiltration during surgery using 200ml of 0.2% plain ropivacaine. 50ml injected following bone preparation prior to implant cementation perpendicular to the posterior femur through the posterior joint capsule in 10ml aliquots. 30ml proximal to the suprapatellar pouch down to the femur.100ml spread into subcutaneous tissues including; collateral and cruciate ligaments, fatty and connective tissue on the anterior aspect of the incision. A 16 gauge epidural catheter inserted via a medial portal, 20ml was injected via the catheter following closure of wound. Post-operatively, patients received boluses of 40ml ropivacaine 0.2% via the catheter using a mechanical McKinley 595 pump 4 hours after leaving theatre, at 22:00 and 08:00 on post-operative day one. Local Infiltration Analgesia (LIA): Subcutaneous infiltration during surgery using 200ml of 0.2% plain ropivacaine.
121
Total242

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath02
Overall StudyLost to Follow-up14
Overall StudyProtocol Violation128

Baseline characteristics

CharacteristicPatient Controlled Epidural (PCEA)Local Infiltration Analgesia (LIA)Total
Age, Continuous66 years
STANDARD_DEVIATION 10
68 years
STANDARD_DEVIATION 11
67 years
STANDARD_DEVIATION 7.6
Body Mass Index31 kilogrammes per meter squared
STANDARD_DEVIATION 8
31 kilogrammes per meter squared
STANDARD_DEVIATION 8
31 kilogrammes per meter squared
STANDARD_DEVIATION 8
Region of Enrollment
United Kingdom
121 participants121 participants242 participants
Sex: Female, Male
Female
66 Participants71 Participants137 Participants
Sex: Female, Male
Male
55 Participants50 Participants105 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1090 / 113
serious
Total, serious adverse events
2 / 1096 / 113

Outcome results

Primary

Proportion of Patients Discharged From Rehabilitation by Day Four

% of patients meeting predetermined discharge criteria at 96 Hours post-surgery. The discharge criteria were: self dependent (dress, personal care); in and out of bedd independently; up and down stairs; walk with crutches/stick; 80 degrees knee flexion; able to straight leg raise operated limb.

Time frame: 96 hours

Population: Patients included following randomisation

ArmMeasureValue (NUMBER)
Patient Controlled Epidural (PCEA)Proportion of Patients Discharged From Rehabilitation by Day Four77 percentage of patients
Local Infiltration Analgesia (LIA)Proportion of Patients Discharged From Rehabilitation by Day Four82 percentage of patients
p-value: 0.332Chi-squared
Secondary

Average Post-operative Length of Stay

Participants will be followed for the duration of hospital stay, an expected average of 5 days

Time frame: Average number of days spent in hospital follwoing surgery, an expected average of 5 days

ArmMeasureValue (MEDIAN)
Patient Controlled Epidural (PCEA)Average Post-operative Length of Stay4 days
Local Infiltration Analgesia (LIA)Average Post-operative Length of Stay4 days
Secondary

Day of Ambulation

Proportion of patients per day to ambulate for the first time with the physiotherapist \> 3 Metres

Time frame: theatre day, day 1 post-surgery, day two post-surgery

ArmMeasureGroupValue (NUMBER)
Patient Controlled Epidural (PCEA)Day of AmbulationTheatre Day35 percentage of patients
Patient Controlled Epidural (PCEA)Day of AmbulationPost-operative day one65 percentage of patients
Patient Controlled Epidural (PCEA)Day of AmbulationPost-operative day two4 percentage of patients
Local Infiltration Analgesia (LIA)Day of AmbulationTheatre Day51 percentage of patients
Local Infiltration Analgesia (LIA)Day of AmbulationPost-operative day one49 percentage of patients
Local Infiltration Analgesia (LIA)Day of AmbulationPost-operative day two0 percentage of patients
Secondary

Maximal Flexion Angle of the Operative Knee at Discharge From Rehabilitation

Time frame: On day of discharge from rehabilitation in-patient care (average 96 hours post surgery)

ArmMeasureValue (MEDIAN)
Patient Controlled Epidural (PCEA)Maximal Flexion Angle of the Operative Knee at Discharge From Rehabilitation80 angle of flexion (degree)
Local Infiltration Analgesia (LIA)Maximal Flexion Angle of the Operative Knee at Discharge From Rehabilitation80 angle of flexion (degree)
Secondary

Patient Reported Outcome Measure - Oxford Knee Score

Units measured on old Oxford Score (12-60) from a 12 point questionnaire. Where in 60 is poor and lower scores are better patient reported outcome scores

Time frame: one week prior to surgery, 6 weeks post-surgery , one year post-surgery

ArmMeasureGroupValue (MEDIAN)
Patient Controlled Epidural (PCEA)Patient Reported Outcome Measure - Oxford Knee ScorePre-operative Oxford Score43 units on a scale
Patient Controlled Epidural (PCEA)Patient Reported Outcome Measure - Oxford Knee ScoreSix week follow up score28 units on a scale
Patient Controlled Epidural (PCEA)Patient Reported Outcome Measure - Oxford Knee ScoreOne year Follow up score19 units on a scale
Local Infiltration Analgesia (LIA)Patient Reported Outcome Measure - Oxford Knee ScorePre-operative Oxford Score43 units on a scale
Local Infiltration Analgesia (LIA)Patient Reported Outcome Measure - Oxford Knee ScoreSix week follow up score26 units on a scale
Local Infiltration Analgesia (LIA)Patient Reported Outcome Measure - Oxford Knee ScoreOne year Follow up score19 units on a scale
Secondary

Post-operative Nausea and Vomiting Scores

percentage of patients reporting either symptoms of nausea or vomiting over the first 72 hours following surgery. Scale 0-2 wherein 0=no nausea and vomiting, 1=nausea and 2= nausea and vomiting

Time frame: 24hours, 48 hours and 72 hours post-surgery

ArmMeasureValue (NUMBER)
Patient Controlled Epidural (PCEA)Post-operative Nausea and Vomiting Scores16 percentage of patients reporting PONV
Local Infiltration Analgesia (LIA)Post-operative Nausea and Vomiting Scores14 percentage of patients reporting PONV
Secondary

Post-operative Urinary Catheterisation Rates

% of patients requiring catheterisation for urinary retention post-surgery

Time frame: 72 hours post-surgery

ArmMeasureValue (NUMBER)
Patient Controlled Epidural (PCEA)Post-operative Urinary Catheterisation Rates9.2 percentage of patients catheterised
Local Infiltration Analgesia (LIA)Post-operative Urinary Catheterisation Rates4.4 percentage of patients catheterised
Secondary

Total Number of Reported Participants With Complications and/or Adverse Events

The composite number of adverse events reported per group at 30 days and then one year post surgery

Time frame: 30 days and one year post-surgery

ArmMeasureGroupValue (NUMBER)
Patient Controlled Epidural (PCEA)Total Number of Reported Participants With Complications and/or Adverse EventsReported complications at 30 days0 participants
Patient Controlled Epidural (PCEA)Total Number of Reported Participants With Complications and/or Adverse EventsReported complications at one year2 participants
Local Infiltration Analgesia (LIA)Total Number of Reported Participants With Complications and/or Adverse EventsReported complications at 30 days2 participants
Local Infiltration Analgesia (LIA)Total Number of Reported Participants With Complications and/or Adverse EventsReported complications at one year4 participants
Secondary

Verbal Rating Score (VRS) Pain Scores

Summary 24 hour Verbal rated numerical pain scores were gathered each day. Scale range 0-10 where 0 is no pain and 10 is worst imaginable pain

Time frame: 24hours, 48 hours and 72 hours post-surgery

ArmMeasureGroupValue (MEAN)Dispersion
Patient Controlled Epidural (PCEA)Verbal Rating Score (VRS) Pain ScoresTheatre Day( asked at 24 hrs)3 units on a scaleStandard Deviation 4
Patient Controlled Epidural (PCEA)Verbal Rating Score (VRS) Pain ScoresPost-operative day one( asked at 48hrs)3 units on a scaleStandard Deviation 3
Patient Controlled Epidural (PCEA)Verbal Rating Score (VRS) Pain ScoresPost-operative day two(asked 72 hrs)3 units on a scaleStandard Deviation 2
Local Infiltration Analgesia (LIA)Verbal Rating Score (VRS) Pain ScoresTheatre Day( asked at 24 hrs)3 units on a scaleStandard Deviation 4
Local Infiltration Analgesia (LIA)Verbal Rating Score (VRS) Pain ScoresPost-operative day one( asked at 48hrs)4 units on a scaleStandard Deviation 3
Local Infiltration Analgesia (LIA)Verbal Rating Score (VRS) Pain ScoresPost-operative day two(asked 72 hrs)4 units on a scaleStandard Deviation 3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026